← All sarcoma trials
Recruiting nowAges 18 Years and up

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Sponsor: Technische Universität Dresden · NCT07148193 on ClinicalTrials.gov ↗

Conditions studied

SarcomaSurvivorshipQuality of Life (QOL)Medical Care

What it tests

  • No intervention (observational study)other

Where it's running5 sites

5 international sites
  • Technical University Dresden

    Dresden, Saxony, Germany

    Recruiting now
  • University Hospital Essen

    Essen, Germany

    Opening soon
    • Uta Dirksen, Prof. Dr.(contact)
  • NCT Heidelberg

    Heidelberg, Germany

    Recruiting now
    • Richard F. Schlenk, Prof. Dr.(contact)
  • Sarcoma Center Mannheim

    Mannheim, Germany

    Recruiting now
    • Jens Jakob, Prof. Dr.(contact)
  • Deutsche Sarkom-Stiftung

    Wölfersheim, Germany

    Recruiting now
    • Markus Wartenberg(contact)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Diagnosis of sarcoma according to the International Classification of Diseases for Oncology (ICD-O) and World Health Organization (WHO) classification, including soft tissue sarcoma, bone sarcoma, and GIST
* At least 5 years since initial sarcoma diagnosis
* With or without active disease
* Age ≥18 years at the time of study participation

Exclusion Criteria:

* Diagnosis of Desmoid tumors
* Inability to complete a structured questionnaire (e.g., due to insufficient German language skills, cognitive impairment, dementia)

Updated 2025-12-08 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.